Horizon Therapeutics PLC (NASDAQ:HZNP)
| 100.30 Delayed Data As of Nov 30 |  +21.51 / +27.30%Today’s Change | 57.84 Today|||52-Week Range 117.49 | -6.92% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Hoelscher Paul W Chief Financial Officer & Executive Vice President |  Sale | 4/06/2022 | 215,335 | $110.01 | $23.7M | -7.95% |
Hoelscher Paul W Chief Financial Officer & Executive Vice President | Sale | 4/06/2022 | 91,710 | $110.01 | $10.1M | -7.95% |
Mchugh Miles W | Sale | 12/01/2021 | 79,484 | $106.62 | $8.5M | -4.89% |
Walbert Timothy P Chairman, President & Chief Executive Officer | Sale | 12/31/2021 | 67,478 | $108.02 | $7.3M | -6.93% |
Walbert Timothy P Chairman, President & Chief Executive Officer | Sale | 1/31/2022 | 74,253 | $91.94 | $6.8M | +7.46% |
Sherman Jeffrey W Chief Medical Officer & Executive Vice President | Sale | 4/06/2022 | 42,009 | $110.02 | $4.6M | -7.95% |
Hoelscher Paul W Chief Financial Officer & Executive Vice President |  Buy | 4/06/2022 | 185,060 | $22.14 | $4.1M | -7.95% |
Walbert Timothy P Chairman, President & Chief Executive Officer | Sale | 3/30/2022 | 35,480 | $105.52 | $3.7M | -5.22% |
Hoelscher Paul W Chief Financial Officer & Executive Vice President | Sale | 4/20/2022 | 28,458 | $114.36 | $3.3M | -13.12% |
Hoelscher Paul W Chief Financial Officer & Executive Vice President | Sale | 3/23/2022 | 26,090 | $110.00 | $2.9M | -7.56% |
Page of 12